Koshi Matsuo

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

In-Stent Yellow Plaque at 1 Year After Implantation Is Associated With Future Event of Very Late Stent Failure

Yasunori Ueda, Koshi Matsuo, Yuji Nishimoto et al. · JACC: Cardiovascular Interventions · 2015 · 81 citations

Cardiovascular Disease, In-stent Yellow Plaque, Implantation Is Associated +6

Relationship Between Coronary Plaque Vulnerability and Serum n-3/n-6 Polyunsaturated Fatty Acid Ratio

Toshikazu Kashiyama, Yasunori Ueda, Takayoshi Nemoto et al. · Circulation Journal · 2011 · 42 citations · Full text

Detection of disrupted plaques by coronary CT: comparison with angioscopy

Mayu Nishio, Yasunori Ueda, Koshi Matsuo et al. · Heart · 2011 · 21 citations

Atherosclerotic Change at One Year After Implantation of Endeavor Zotarolimus-Eluting Stent vs. Everolimus-Eluting Stent

Yasuhiro Akazawa, Koshi Matsuo, Yasunori Ueda et al. · Circulation Journal · 2014 · 20 citations · Full text